MYCN-amplified tumours (n=32 out of 33; one specimen was not available for GATA-4 analysis) expressed significantly more GATA-4 than MYCN-nonamplified (n=218) tumours (Figure 4A; P=0.001). The gene discussed is MYCN; the disease is neoplasm.